Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.

Wimolsiri Iamsumang, Kanchana Leerunyakul, Poonkiat Suchonwanit

Review Drug design, development and therapy 2020 66 인용

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D32184564'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

연구 유형: Review

중재: Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. None
대조군: Placebo
효과 방향: Positive
비뚤림 위험: Unclear

Abstract

The currently approved treatment for female pattern hair loss (FPHL) includes topical minoxidil administration; however, this treatment fails to achieve hair regrowth in some patients. Finasteride, a selective 5α-reductase inhibitor (5-ARI), may be considered as an alternative treatment. However, because of its potential teratogenic effects, clinical studies and use of finasteride for FPHL are limited. In this review, we aim to summarize the literature regarding the pharmacology, clinical efficacy, and adverse effects of oral finasteride for the treatment of FPHL and to provide novel therapeutic options including topical finasteride and dutasteride, a new generation 5-ARI, for the treatment of FPHL.

Used In Evidence Reviews

Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.

Embed This Widget

Study Design

Abstract

Used In Evidence Reviews

Similar Papers

Secular trends in dietary intake in the United States.

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

Androgenetic alopecia: a review.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.

Alopecia areata.